Objectives: To determine the diagnostic accuracy of the Check-Direct ESBL Screen for BD MAX (ESBL qPCR) and an ESBL culture method to identify ESBLs directly from rectal swabs.
Introduction
In Europe, ESBL enzymes are found increasingly frequently among members of the family Enterobacteriaceae. [1] [2] [3] ESBLs are mostly located on plasmids enabling microorganisms to hydrolyse penicillins, broad-spectrum cephalosporins and monobactams. 4 Some studies have reported that ESBL-producing microorganisms possess co-resistance to other antibiotics such as co-trimoxazole, fluoroquinolones and/or aminoglycosides, complicating antimicrobial therapy in infected patients. [5] [6] [7] In the Netherlands, several studies have shown that ESBL colonization prevalence rates range between 3.5% and 10.1%, depending on the population and region. [8] [9] [10] [11] As infections with ESBLs are associated with increased morbidity, mortality and healthcare costs, a fast and accurate detection, as well as the prevention of transmission in healthcare facilities, is important. 12, 13 For these reasons and to shorten the (unnecessary) isolation time of patients, it has become important to develop a rapid diagnostic test to identify ESBLs directly from rectal swabs. In Dutch hospitals, patients recently admitted to a foreign hospital are screened for colonization with MDR microorganisms (MDROs) including ESBLs. 14 As part of this policy, patients are nursed in isolation while waiting for their test results. Typical routine laboratory detection of ESBLs is based on phenotypic tests using chromogenic culture media, followed by a confirmation step, such as the combination disc method. 15 The main disadvantage of phenotypic testing is the relatively long turnaround time (TAT), which can be up to 5 days depending on the growth rate of the microorganism. [16] [17] [18] Earlier studies have described the diagnostic accuracy of fast, modern molecular techniques, such as real-time PCR for the detection of MRSA, VRE and carbapenemase-producing Enterobacteriaceae (CPE) directly from clinical samples. [19] [20] [21] [22] [23] [24] Recently, a commercially available multiplex real-time PCR for detecting ESBLs directly from rectal swabs using the BD MAX system (BD Diagnostics, Sparks, MD, USA) was developed: the CheckDirect ESBL Screen for BD MAX (Check-Points, the Netherlands). The results of this test are available within a few hours and differentiate between four ESBL groups (bla CTX-M-1 group, bla CTX-M-2 group, bla CTX-M-9 group and bla SHV ESBL group), which is helpful in revealing the epidemiology of the different resistance genes.
The present study was designed and performed at the Regional Public Health Laboratory Kennemerland (RPHLK) as a prospective study that aimed to determine the diagnostic accuracy of the Check-Direct ESBL Screen for BD MAX (ESBL qPCR) and a ESBL culture method to identify ESBLs directly from rectal swabs. Calculated measures of diagnostic accuracy were sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) and optimal cycle threshold (Ct) cut-off value.
Methods

Ethics
According to the Dutch regulation for research with human subjects, neither medical nor ethics approval was required to conduct the study because the data were collected as part of each hospital's standard infection control programme. The data were analysed in a pseudonymized manner.
Study design and participants
The present diagnostic accuracy study was prospectively performed in October 2015. Rectal swabs (Copan eSwab stored in 1 mL of modified liquid Amies) were obtained from clinical patients by performing cross-sectional (point)prevalence measurements in the three regional hospitals in the Dutch region of Kennemerland as part of each hospital's infection control programme. All non-clinical patients were excluded. Rectal swabs were processed within 24 h at the RPHLK by performing the direct ESBL culture test and the ESBL qPCR side by side followed by a discrepant analysis on discordant samples. The patient identification was pseudonymized.
Phenotypic detection of ESBLs
ESBL culturing was performed following the standard operating procedure at the RPHLK by direct culture of rectal swabs on ChromID ESBL agar (bioMérieux), which is a chromogenic agar enriched with a mixture of antibiotics, including cefpodoxime. All Gram-negative bacilli growing were determined using MALDI-TOF MS (Bruker Daltonics, Germany), and antibiotic susceptibility testing was performed using the automated system VITEK2 (bioMérieux). Suspected ESBL producers, identified by the VITEK2 Advanced Expert System, and/or elevated MIC (.1 mg/L) for cefotaxime and/or ceftazidime, were confirmed with the combination disc method using ceftazidime and cefotaxime or cefepime with and without clavulanic acid based on bacterial species. 15 Isolates were interpreted as ESBL positive when the inhibition zone was 5 mm larger with clavulanic acid than without. All ESBL-positive isolates were stored at #80 C. 
Check-Direct ESBL Screen for BD MAX
Molecular characterization of ESBL-positive isolates by WGS
DNA was extracted using the UltraClean microbial DNA isolation kit (Mo Bio Laboratories, Carlsbad, CA, USA) according to the manufacturer's protocol. A DNA library was prepared using the Nextera XT kit (Illumina, San Diego, CA, USA) according to the manufacturer's instructions. Subsequently, WGS was performed using the MiSeq instrument (Illumina) for generating paired-end 250 bp reads, aiming at a coverage of at least 60-fold. De novo assembly was performed as described previously using CLC Genomics Workbench version 7.0.3 (CLC bio A/S, Aarhus, Denmark) after quality trimming (Qs 28) with optimal word sizes based on the maximum N50 value. 25, 26 The ST was identified by uploading the assembled genomes to the MLST server (version 1.7) and the acquired resistance genes were determined with the CGE Resfinder 1.2 tool.
27,28
Discrepant analysis and gold standard
Rectal swabs that were ESBL negative with the direct ESBL culture method and ESBL positive with the ESBL qPCR were reanalysed by inoculating a non-selective enrichment broth (thioglycolate) and subcultured in the ChromID ESBL agar. All isolates growing were determined, characterized and interpreted as described earlier with the ESBL culture test. As gold standard, rectal swabs were interpreted as true ESBL positive when a microorganism with an ESBL gene was isolated, using WGS analysis. Rectal swabs were interpreted as true ESBL negative when no microorganism or when a microorganism without an ESBL gene was isolated using WGS analysis.
Data analysis
The sensitivity, specificity, NPV and PPV of the ESBL qPCR and direct ESBL culture method were determined by using two-by-two contingency tables and analysed using the McNemar test for paired samples. The difference in mean Ct value between ESBL qPCR true-positive and false-positive rectal swabs was analysed using Student's t-test. In addition, a receiver operating characteristic (ROC) curve for different values of sensitivity and specificity was created and reported as area under curve (AUC). The optimal Ct cut-off value was calculated from the combination of sensitivity and specificity with the highest corresponding Youden index [(sensitivity ! specificity) # 1]. 29 In order to use negative ESBL qPCR rectal swabs in the analysis of optimal Ct cut-off, a value of 40 was filled in for these samples as in practice these samples had no Ct value. All data were analysed using PASW SPSS Statistics version 18.0 and results were interpreted as statistically significant when P values were ,0.05.
Results
Rectal swabs and patient characteristics
In October 2015, 354 rectal swabs (of 351 patients) were collected as part of the infection control programme in the three hospitals under study. From three patients, two rectal swabs were collected (different days, due to change of ward) and were included in the analysis of diagnostic accuracy. Rectal swabs from two other patients showed inhibition with the ESBL qPCR and were excluded Check-Points Check-Direct ESBL Screen for BD MAX JAC from further analyses, resulting in 352 available rectal swabs (of 349 patients).The mean age (SD) of the patients was 63.1 years (23.7) and 184 patients were female (52.4%). Other characteristics of the included patients are shown in Table 1 .
Initial test results of the direct ESBL culture test and ESBL qPCR
The direct ESBL culture method detected 20 ESBL-positive rectal swabs (19 patients). Isolated microorganisms were Escherichia coli (53.1%) followed by Klebsiella pneumoniae (25.0%) and Enterobacter cloacae (21.9%). The ESBL qPCR detected ESBL in 28 rectal swabs (27 patients). Concordant results were found in 340 rectal swabs (96.6%, 18 positive and 322 negative).
Discordant results, discrepant analysis and final interpretation
Discordant results were found in 12 of the 352 rectal swabs (3.4%). Two rectal swabs were ESBL positive with the direct ESBL culture method and negative with the ESBL qPCR (samples 19 and 20 in Table 2 ). WGS analysis of the isolated microorganism of sample 19 revealed a bla TEM ESBL. Sample 19 was therefore classified as ESBL positive (false-negative ESBL qPCR). The isolated microorganism of sample 20 showed no ESBL resistance genes and was therefore classified as ESBL negative (false-positive direct ESBL culture).
Ten rectal swabs were ESBL negative with the direct ESBL culture method and ESBL positive with the ESBL qPCR. Discrepant analyses of these 10 rectal swabs revealed that two rectal swabs contained an ESBL-positive microorganism (after subculturing from a non-selective enrichment broth) and were confirmed by WGS (samples 21 and 22 in Table 2 
Molecular characterization of ESBL-positive isolates
Twenty-five ESBL-positive isolates belonging to 20 ESBL-positive patients were genotyped by WGS. In total, 27 ESBL genes were recovered: bla CTX-M-15 (n " 13, 48.2%), bla CTX-M-1 (n " 3, 11.1%), bla SHV-12 (n " 3, 11.1%), bla CTX-M-14 (n " 2, 7.4%), bla CTX-M-27 (n " 2, 7.4%), bla CTX-M-9 (n " 1, 3.7%), bla CTX-M-14b (n " 1, 3.7%), bla SHV-28 (n " 1, 3.7%) and bla TEM-12 (n " 1, 3.7%).
Fifteen of the 25 ESBL-positive isolates were determined as E. coli (60.0%). ST131 and ST162 were both found twice (13.3%). All other ESBL-positive E. coli STs were found once (n " 1, 6.7%) and included ST10, ST38, ST48, ST88, ST95, ST410, ST540, ST635, ST648, ST6027 and a new ST (ST6900). Six ESBL-positive isolates were determined as K. pneumoniae (24.0%), consisting of ST15, ST16, ST20, ST215, ST1017 and a new ST (ST2459). The other four ESBL-positive isolates were determined as E. cloacae (16.0%), consisting of ST50 and three new STs (ST848, ST850 and ST851).
Measures of diagnostic accuracy and Ct cut-off value
The ESBL qPCR showed a sensitivity of 95.2% (20/21), a specificity of 97.6% (323/331), a PPV of 71.4% (20/28) and an NPV of 99.7% (323/324). For the direct ESBL culture method a sensitivity of 90.5% (19/21), a specificity of 99.7% (330/331), a PPV of 95.0% (19/20) and an NPV of 99.4% (330/332) was found when calculated after discordant analysis. The McNemar test for paired samples between the ESBL qPCR and direct ESBL culture method showed a significant difference in distribution (P " 0.039) attributable to the difference in specificity (Table 3) .
Comparing mean Ct values of ESBL qPCR true ESBL positive (Ct " 24.5, n " 20) and false ESBL positive (Ct " 35.9, n " 8) rectal swabs showed a significant difference (11.4, P , 0.01). In order to determine the optimal Ct cut-off value an ROC curve and the corresponding AUC value (0.975, 95% CI " 0.922-1, P , 0.01) were calculated by plotting serial sensitivities and specificities at various Ct cut-off values. The highest Youden index was found at a Ct cutoff value of 37, corresponding to a sensitivity of 95.2% (20/21) and a specificity of 98.8% (327/331).
Discussion
Here, we report the diagnostic accuracy of the Check-Direct ESBL Screen for BD MAX (ESBL qPCR) and a direct ESBL culture method to identify ESBLs directly from rectal swabs. Both methods were performed simultaneously on 352 rectal swabs, as part of a (point) prevalence measurement from three hospitals. The sensitivity and specificity of the ESBL qPCR were 95.2% (20/21) and 97.6% (323/331), respectively. The sensitivity and specificity of the direct ESBL culture method were 90.5% (19/21, P " 1.000) and 99.7% (330/331, P " 0.039), respectively. Two of the ESBL-positive rectal swabs were positive after subculturing from a non-selective enrichment broth. One rectal swab was ESBL negative with the ESBL qPCR and positive after culturing. WGS analysis revealed a bla TEM-12 ESBL gene in this isolate. However, bla TEM ESBL is not incorporated as a target in the ESBL qPCR. It should be noted that in regions with a high prevalence of bla TEM ESBL this ESBL qPCR is not suitable as these samples would be classified as ESBL negative. In addition, several prevalence studies have shown that bla TEM ESBLs are still prevalent among hospitalized patients in the Netherlands. 8, 30 Furthermore, eight ESBL qPCR-positive rectal Two swabs showed inhibition with the ESBL qPCR and were excluded from further analysis; from three patients two rectal swabs were collected (another day, admitted on another ward) and were included in the analysis of diagnostic accuracy. Souverein et al. Check-Points Check-Direct ESBL Screen for BD MAX JAC swabs could not be confirmed with growth of ESBL-producing microorganisms and were classified as false-positive ESBL qPCR. In comparison, Lau et al. 24 analysed rectal swabs with a direct CPE qPCR and a direct culture method as gold standard. This CPE qPCR demonstrated a sensitivity and specificity of 100% and 88%, respectively, and a PPV of 21% as 34 samples were negative by culturing. Several other studies reported similar conclusions for the detection of CPE in clinical specimens as a large proportion of qPCR-positive specimens could not be confirmed by culturing. 22, 23 Sittov a et al. 31 performed a comparable study to identify ESBLs directly from endotracheal aspirates by qPCR. Their sensitivity and specificity were 96% and 89%, respectively. In addition, a large proportion of the ESBL qPCR-positive samples were culture negative, resulting in a low PPV of 43%. The interpretation of these qPCR-positive and culture-negative samples is hindered by the lack of a true gold standard. There could be several explanations for these discrepancies which are also applicable to our false-positive qPCR results. First, culturing is possibly insensitive, classifying false ESBL qPCR samples incorrectly as false positive. However, some studies reported that the limit of detection for CPE was equivalent or better with increasing dilutions using culturing compared with qPCR. 24 It is likely that these results are also applicable to ESBL detection. Second, after initial culturing (without enrichment) all swabs were frozen and subsequently defrosted and cultured (after enrichment) when a discordant result was found. Several studies have shown that initial pre-enrichment increased the detection sensitivity of ESBLs up to 25%. 32, 33 However, as we performed our discrepant analysis (using a non-selective enrichment broth) only after freezing, we potentially missed true ESBL-positive rectal swabs as freezing has a potential negative effect on detection sensitivity. Therefore, we could not rule out that the choice of the initial culture test marked some discordant rectal swabs unfairly as ESBL negative. Consequently, the specificity and PPV of the ESBL qPCR are probably higher than reported in this study. Third, it may be possible that the ESBL qPCR detected ESBLs from non-viable microorganisms. Fourth, it is possible that these rectal swabs were ESBL qPCR positive due to off-target amplification and are actually false positive. Most of the discordant results could be answered by sequencing of the amplified product as this analysis could confirm the qPCR result, but has also been criticized because this type of confirmatory testing would introduce bias to the qPCR result. 34 Unfortunately we could not perform this analysis within the current study.
Comparing mean Ct values of true-positive and false-positive ESBL qPCR rectal swabs showed a large difference in mean Ct value of 11.4, indicating the possibility of using a Ct cut-off value. In our study, a Ct cut-off value of 37 was optimal as four patients shifted from false positive to true negative, without compromising the sensitivity. The specificity improved from 97.6% to 98.8% and the PPV from 71.4% to 83.3%. For now, we cannot recommend the use of a Ct cutoff value as more studies that analyse the performance of the ESBL qPCR in different populations are needed, to confirm our results. Several studies that analysed Ct values of a CPE qPCR showed a large overlap, resulting in a misclassification of true-positive patients. 22, 24 In laboratories and hospitals this ESBL qPCR could be implemented in various settings such as screening of high-risk groups on admission, but also as a fast screening test in an outbreak setting. O'Connor et al. 35 implemented a new laboratory workflow using a direct CPE qPCR showing a time to result within 4 h. However, it is unknown if qPCR screening is cost-effective compared with standard culturing. In the Netherlands, screening and pre-emptive isolation of high-risk groups includes the screening of various MDROs besides ESBL, such as CPE, MRSA and VRE.
14 In daily practice, patients need to test negative for all these MDROs in order to lift isolation precautions, requiring the performance of various qPCRs side by side to take full advantage of fast test results. Given the fact that a relatively low PPV will result in a substantial number of falsepositive patients, one should make a thorough assessment of the potential benefits (fast test results) and disadvantages (higher costs and high false-positive rate). For this reason, culturing and the ESBL qPCR should always be performed side by side in order to correct for possible false-positive or -negative results. Unnecessary isolation of suspected positive patients should be prevented as this is associated with lower quality of patient care, increased hospital admission costs, unnecessary use of isolation rooms and an increased number of preventable adverse events. 36 However, in an outbreak setting, with higher incidences of ESBL-positive patients, this ESBL qPCR could be a suitable test as the sensitivity (95.2%) and NPV (99.7%) are fairly high and can accurately rule out ESBL colonization. In addition, when a patient tests ESBL positive, four ESBL subtypes can be distinguished (bla CTX-M-1 group, bla CTX-M-2 group, bla CTX-M-9 group and bla SHV ESBL group) which could be important in outbreaks as this provides important epidemiological information.
The present study had several limitations. First, this study was performed in a region with a relatively low prevalence of ESBL colonization and low prevalence of bla TEM ESBL. Therefore, we advise other hospitals and laboratories to include targeted population, local ESBL epidemiology and ESBL prevalence in the choice of the most appropriate screening method. Second, we did not perform a sequencing analysis of the amplified product. This could improve the understanding on how to interpret McNemar test for the difference in specificity between the ESBL qPCR and direct culture: P " 0.039.
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false-positive ESBL qPCR results. Third, we did not perform an initial pre-enrichment step before culturing. It is likely that some rectal swabs are incorrectly classified as ESBL negative. However, with our discrepant analysis on discordant results we have tried to minimize this bias.
In conclusion, the Check-Direct ESBL Screen for BD MAX offers rapid detection of the most prevalent types of bla CTX-M and bla SHV ESBL from rectal swabs. However, due to the relatively high falsepositive rate this test is most suitable in high-prevalence regions or in an outbreak setting where a fast test result is essential and false-positive results are less important.
